SETD1A and Alzheimer disease: We used nomograph to construct a disease prediction model, which showed that the higher the expression of KAT7, SMARCA5, and SETD1A, the higher the probability of developing AD, and the higher the expression of CHD4 and EHMT2, the lower the probability of developing AD (Fig. 7).